Parallel Advisors, LLC Adma Biologics, Inc. Transaction History
Parallel Advisors, LLC
- $4.31 Billion
- Q1 2025
A detailed history of Parallel Advisors, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 520 shares of ADMA stock, worth $10,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
520
Previous 454
14.54%
Holding current value
$10,535
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ADMA
# of Institutions
340Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$378 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$369 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$301 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$229 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$112 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.98B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...